Global Clinical Trial Supplies Market Size & Trends

Global Clinical Trial Supplies Market Size & Trends

According to a new market research report published by Global Market Estimates, the Global Clinical Trial Supplies Market is projected to grow from USD 2.1 Billion in 2022 to USD 2.9 Billion in 2027 at a CAGR value of 8.5% from 2022 to 2027.

The growing number of clinical trials across the globe, stringent regulatory restrictions, and guidelines for drug approval that varies region by region, growing incidence of infections, and rising investment in cancer research are expected to propel the clinical trial supplies market forward.

Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and indepth TOC on “Global Clinical Trial Supplies Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/clinical-trial-supplies-market3890

By Clinical Phase (Phase I, Phase II, Phase III, Others), By Service (Manufacturing, Storage & Distribution, Supply Chain Management), By Therapeutic Use (Oncology, Diabetes), By End Use (Pharmaceuticals, CROs), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Key Market Insights 

As per the clinical phase outlook, the Phase 3 segment is expected to be the largest

 

segment in the clinical trial supplies market from 2022 to 2027 The Asia Pacific region is analyzed to be the fastest-growing segment in the market United States has the largest share in the market during the forecast period of 2022-



2027.

As per the service, the supply chain management segment is expected to be the largest segment in the clinical trial supplies market from 2022 to 2027



Catalent, Inc. (US), Almac Group (UK), Biocair (US), SIRO Clinpharm Private Limited (India), Sharp (Japan), Parexel International Corporation (US), Alium Medical Limited (UK), Ancillare, LP. (US) and Thermo Fisher Scientific Inc. (US) among others, are some of the key players in the clinical trial supplies market.

Clinical Phase Outlook (Revenue, USD Billion, 2022-2027)    

Phase I Phase II Phase III Others

Service (Revenue, USD Billion, 2022-2027) 

Manufacturing



Storage & Distribution



Supply Chain Management

Therapeutic Use Outlook (Revenue, USD Billion, 2022-2027) 

Oncology



Diabetes

End Use Outlook (Revenue, USD Billion, 2022-2027) 

Pharmaceuticals



CROs

Regional Outlook (Revenue, USD Billion, 2022-2027) North America   

The U.S. Canada Mexico

Europe       

Germany UK France Spain Italy Netherlands Rest of Europe

Asia Pacific          

China India Japan South Korea Thailand Indonesia Malaysia Singapore Vietnam Rest of APAC

Central & South America    

Brazil Argentina Chile Rest of CSA

Middle East & Africa     

Saudi Arabia UAE Israel South Africa Rest of MEA

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238